Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements.
García-González P, Tempio F, Fuentes C, Merino C, Vargas L, Simon V, Ramirez-Pereira M, Rojas V, Tobar E, Landskron G, Araya JP, Navarrete M, Bastias C, Tordecilla R, Varas MA, Maturana P, Marcoleta AE, Allende ML, Naves R, Hermoso MA, Salazar-Onfray F, Lopez M, Bono MR, Osorio F. García-González P, et al. Among authors: lopez m. Front Immunol. 2021 Oct 21;12:769059. doi: 10.3389/fimmu.2021.769059. eCollection 2021. Front Immunol. 2021. PMID: 34745145 Free PMC article.
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A, López M, Serrano A, Ramirez M, Pérez C, Aguirre A, González R, Alfaro J, Larrondo M, Fodor M, Ferrada C, Salazar-Onfray F. Escobar A, et al. Among authors: lopez m. Clin Exp Immunol. 2005 Dec;142(3):555-68. doi: 10.1111/j.1365-2249.2005.02948.x. Clin Exp Immunol. 2005. PMID: 16297169 Free PMC article. Clinical Trial.
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
López MN, Pereda C, Segal G, Muñoz L, Aguilera R, González FE, Escobar A, Ginesta A, Reyes D, González R, Mendoza-Naranjo A, Larrondo M, Compán A, Ferrada C, Salazar-Onfray F. López MN, et al. J Clin Oncol. 2009 Feb 20;27(6):945-52. doi: 10.1200/JCO.2008.18.0794. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139436 Clinical Trial.
Interleukin 10 decreases MICA expression on melanoma cell surface.
Serrano AE, Menares-Castillo E, Garrido-Tapia M, Ribeiro CH, Hernández CJ, Mendoza-Naranjo A, Gatica-Andrades M, Valenzuela-Diaz R, Zúñiga R, López MN, Salazar-Onfray F, Aguillón JC, Molina MC. Serrano AE, et al. Among authors: lopez mn. Immunol Cell Biol. 2011 Mar;89(3):447-57. doi: 10.1038/icb.2010.100. Epub 2010 Aug 17. Immunol Cell Biol. 2011. PMID: 20714339
Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells.
Aguilera R, Saffie C, Tittarelli A, González FE, Ramírez M, Reyes D, Pereda C, Hevia D, García T, Salazar L, Ferreira A, Hermoso M, Mendoza-Naranjo A, Ferrada C, Garrido P, López MN, Salazar-Onfray F. Aguilera R, et al. Among authors: lopez mn. Clin Cancer Res. 2011 Apr 15;17(8):2474-83. doi: 10.1158/1078-0432.CCR-10-2384. Epub 2011 Feb 3. Clin Cancer Res. 2011. PMID: 21292818 Clinical Trial.
7,273 results